In this episode, we will explore the ways that antimicrobial resistance impacts treatment for some of the most vulnerable patients, such as those undergoing cancer treatment or receiving bone marrow transplants. A recent survey of oncologists showed that 95% of them worry about the impact of superbugs on the future of cancer treatments, and one in five patients receiving chemotherapy will have a bacterial infection. In this episode, you will hear directly from a patient who had a bacterial infection while fighting cancer, from front-line clinicians, and from a researcher driving policy at a national level.
Learn more about our guests this episode:
This podcast is co-created by CIDRAP-ASP and the Antimicrobial Resistance Fighter Coalition (ARFC).